Treatment of Single and Multiple Food Allergies with ADP101: Results of the Harmony Phase 1/2 Trial

The phase 1/2 Harmony trial (NCT04856865) evaluated ADP101, a pharmaceutical-grade, investigational multifood oral immunotherapy (mOIT) for simultaneous treatment of allergy to 1-5 foods in ADP101 (almond, cashew, chicken ’s egg, codfish, cow’s milk, hazelnut, peanut, pecan, pistachio, salmon, sesame, shrimp, soy, walnut, wheat).
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Source Type: research